His appointment was approached, it is now official. Olivier Brandicourt will become the new CEO of Sanofi on April 2. The man who led the pharmaceutical branch of Bayer joined the French pharmaceutical giant, which had no boss since late October of eviction Chris Viehbacher, the dual German and Canadian citizenship. The acting was provided for by the Chairman of the Board Serge Weinberg, a former senior official in the converted equity
Read (subscribers edition). The head of Bayer Pharma tipped to take the lead Sanofi
A physician, Dr. Brandicourt has international experience of 28 years in the pharmaceutical industry, Sanofi said in the statement announcing his arrival Thursday, February 19, recalling his visits at Warner-Lambert, Pfizer and Bayer finally. Mr. Brandicourt in particular is part of the executive committee of Pfizer, the world’s largest pharmaceutical group, between 2010 and 2013.
“The extensive experience of Olivier Brandicourt combined with its international profile in its perfect knowledge of the US market and emerging health markets, and its ability to unite teams will revitalize the strategy of diversification and innovation Sanofi “, Weinberg has shown to explain this choice
“By directing several key divisions of Health (Mr. Brandicourt) acquired a wide field of expertise and knowledge of the pharmaceutical industry.; it was at the initiative of launching many products and has completed strategic acquisitions and integration “, further argued Sanofi. During the presentation of its annual results in early February, the group stated that the announcement of the new CEO, recruited externally, would be made “in the first quarter” .
Read (subscribers edition): Sanofi has struggled to find a new boss